Justin Hall, CEO, GC and Director at NovaBay Pharmaceuticals, Inc. (NBY), bought 10,000 shares at $0.15 ($2K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market purchase of $2k NBY by CEO, GC and Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |